The Full Library
Every article, guide, and research update — all in one place.
6 articles publishedP21 for GLP-1 Cognitive Fog: VA Trial Lessons
GLP-1 agonists can cause cognitive fog, but a 2023 VA trial on P21 for alcohol-related impairment offers clues. This peptide improved executive function
P21 and GLP-1 Alcohol Trials: Cognitive Fog in Veterans
Veterans in GLP-1 alcohol trials sometimes face cognitive fog that hinders participation. This article explores P21, a synthetic peptide, as a potential
P21 and Pinealon Synergy for Age-Related Cognitive Decline
P21 and Pinealon, two peptides under FDA review as a nootropic stack, target age-related cognitive decline through neurogenesis and epigenetic
Selank for Performance Anxiety Under FDA Scrutiny
Selank, a synthetic tuftsin analogue, shows promise for anxiety without sedation, but FDA scrutiny and a lack of performance-specific trials leave its future
P21 for Chemobrain: Can This Peptide Reverse Chemotherapy-Induced Cognitive Decline?
Chemobrain affects up to 50% of cancer survivors, yet no approved treatment exists. The peptide P21 shows promise in animal studies by boosting
P21 vs. Cerebrolysin for Post-Concussion Cognitive Rehabilitation
Comparing P21 and Cerebrolysin for post-concussion cognitive recovery: a walk through the preclinical and clinical evidence, mechanisms, safety, and